When it comes to selling an addiction treatment center, one question matters most: “What multiple can I expect?” That multiple — typically expressed as a range of your EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) — determines how much your center is worth to a buyer. But not all rehabs are valued equally. Two... View Article...
Key Takeaways 2026 deal activity expected to rebound after 2025’s slower pace Add-on acquisitions outpacing new platform deals as PE portfolios mature Integration of SUD and mental health services driving strategic value Smaller facilities ($2-10M revenue) seeing increased buyer interest Preparation is key — start with a Drug Rehab Valuation See what’s currently on the... View Article...
The behavioral health sector continues to attract private equity groups, strategic buyers, and independent operators who see strong demand and long-term growth potential. But not every treatment center is a good investment. At Addiction-Rep, we’ve evaluated hundreds of facilities nationwide and advised buyers on acquisitions ranging from small outpatient programs to multi-state platforms. Whether you’re... View Article...
Key Takeaways Clean financials and stable census are the two biggest value drivers for treatment centers EBITDA multiples for quality rehabs range from 4-7x depending on size and payer mix Get a professional valuation before listing — see our Drug Rehab Valuation Services Confidentiality is critical — work with a broker who specializes in treatment... View Article...
Key Takeaways Staffing costs now represent 50-60% of treatment center operating expenses Buyers discount valuations for facilities with high turnover or vacancy rates Telehealth integration and flexible scheduling are becoming value drivers Retention programs and competitive pay can increase your sale price Understand how staffing impacts your valuation — see Drug Rehab Valuation Guide Browse... View Article...
KEY TAKEAWAYS 2026 is a rebound year for addiction treatment M&A after a cooling period in 2025 Private equity and strategic healthcare buyers remain active, favoring add-on acquisitions U.S. addiction treatment market valued at $143.62B in 2024, projected to reach $408.12B by 2033 Getting a professional valuation is essential before listing — see our Drug... View Article...
Key Takeaways Behavioral health valuations are stabilizing after the 2021-2022 peak Quality assets with diversified payer mix still command premium multiples Private equity focus has shifted to platform building and operational improvements Integration of mental health and SUD services increases enterprise value Request your facility valuation at Drug Rehab Valuations As we move through 2026,... View Article...
Key Takeaways Revenue quality (payer mix) matters more than total revenue EBITDA margin benchmarks: 15-25% for residential, 25-40% for outpatient Licensure, accreditation (CARF/Joint Commission), and compliance are table stakes Real estate ownership can add significant value or complicate deals Census stability and referral diversity reduce buyer risk Get your facility valued at Drug Rehab Valuations... View Article...
Introduction If you own an addiction treatment center, understanding its true market value is no longer optional — it’s essential. Whether you plan to sell, seek investment, or simply measure growth, your valuation defines how the market perceives your business. At Addiction-Rep, we’ve helped treatment centers across the U.S. secure millions in equity through transparent,... View Article...
Artificial Intelligence is transforming the global workforce faster than any previous wave of technology. From data entry to copywriting, automation is taking over repetitive, rules-based work at incredible speed. But amid this transformation, there’s a growing awareness that some jobs — especially those rooted in empathy, creativity, and complex human judgment — will endure. In... View Article...
